Wearable Injectors Market by Type (On-body {Adhesive Patch}, Off-body {Belt Clip}, and Hand-held), Usage (Disposable and Semi-reusable), Technology (Electronic Injectors, Mechanical Injectors, and Others), Mechanism of Injection (Motor-driven, Spring-based, Expanding Battery, Rotary Pump, Collapsible Reservoir, and Pressurized Gas), Therapeutic Area (Diabetes, Oncology, Cardiovascular Diseases, Infectious Diseases, and Auto-immune Disorders), and End User (Clinics, Hospitals, Ambulatory Surgery Centers, Home Care Settings, and Others) - Global Opportunity Analysis and Industry Forecast, 2019-2026
|
LI_183755
|
Pages: NA
|
Nov 2019 |
1163 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Wearable injectors are drug delivery devices based on single-use wearable device technologies, designed to deliver drugs in large volume to the patients treated for long duration. Rapid ongoing developments with many new designed features of these have been witnessed in the medical field. Wearable injectors offer numerous benefits to the patients due to their wide usage.
The global wearable injectors market is driven by the advantages as compared to traditional injectors, ease of customization, and increase in demand for home healthcare and advanced drug delivery system. Growth in need for subcutaneous and continuous drug delivery has created the demand for wearable injectors among the patients. However, low dosing volume of administering drugs and highly viscous nature of few drugs impede the market growth. Moreover, rise in need for better patient care and growth in focus of pharmaceutical companies to penetrate in the market offer ample opportunities for market development.
The global wearable injectors market is segmented based on type, usage, technology, mechanism of injection, therapeutic area, end user, and region. On the basis of type, it is divided into on-body {adhesive patch}, off-body {belt clip}, and hand-held. Based on usage, it is bifurcated into disposable and semi-reusable. Based on technology, it is classified into electronic injectors, mechanical injectors, and others. On the basis of mechanism of injection, it is categorized into motor-driven, spring-based, expanding battery, rotary pump, collapsible reservoir, and pressurized gas. On the basis of therapeutic area, it is divided into diabetes, oncology, cardiovascular diseases, infectious diseases, and auto-immune disorders. Based on end user, it is divided into clinics, hospitals, ambulatory surgery centers, home care settings, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market are Enable Injections, SteadyMed Therapeutics, Inc., Insulet Corporation, UNILIFE CORPORATION, Sensile Medical AG, West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Bhler Motor GmbH, Ypsomed, and Amgen Inc.,
Key Benefits
- The study provides an in-depth analysis of the global wearable injectors market along with current trends and future estimations to elucidate the imminent investment pockets.
- It presents a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market by product assists to understand the various forms of wearable injectors available.
- Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.
Wearable Injectors Market Key Segments:
By Type
- On-body (adhesive patch)
- Off-body (belt clip)
- Hand-held
By Usage
Disposable
- Semi-reusable
By Technology
- Electronic Injectors
- Mechanical Injectors
- Others
By Mechanism of Injection
- Motor-driven
- Spring-based
- Expanding Battery
- Rotary Pump
- Collapsible Reservoir
- Pressurized Gas
By Therapeutic Area
- Diabetes
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Auto-immune Disorders
By End User
- Clinics
- Hospitals
- Ambulatory Surgery Centers
- Home Care Settings
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 WEARABLE INJECTORS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ON-BODY (ADHESIVE PATCH)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. OFF-BODY (BELT CLIP)
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. HAND-HELD
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 WEARABLE INJECTORS MARKET, BY USAGE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. DISPOSABLE
5.2.1. Market size and forecast
5.3. SEMI-REUSABLE
5.3.1. Market size and forecast
CHAPTER 6 WEARABLE INJECTORS MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. ELECTRONIC INJECTORS
6.2.1. Market size and forecast
6.3. MECHANICAL INJECTORS
6.3.1. Market size and forecast
6.4. OTHERS
6.4.1. Market size and forecast
CHAPTER 7 WEARABLE INJECTORS MARKET, BY MECHANISM OF INJECTION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. MOTOR-DRIVEN
7.2.1. Market size and forecast
7.3. SPRING-BASED
7.3.1. Market size and forecast
7.4. EXPANDING BATTERY
7.4.1. Market size and forecast
7.5. ROTARY PUMP
7.5.1. Market size and forecast
7.6. COLLAPSIBLE RESERVOIR
7.7. PRESSURIZED GAS
7.7.1. Market size and forecast
CHAPTER 8 WEARABLE INJECTORS MARKET, BY THERAPEUTIC AREA
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. DIABETES
8.2.1. Market size and forecast
8.3. ONCOLOGY
8.3.1. Market size and forecast
8.4. CARDIOVASCULAR DISEASES
8.4.1. Market size and forecast
8.5. INFECTIOUS DISEASES
8.5.1. Market size and forecast
8.6. AUTO-IMMUNE DISORDERS
8.6.1. Market size and forecast
CHAPTER 9 WEARABLE INJECTORS MARKET, BY END USER
9.1. OVERVIEW
9.1.1. Market size and forecast
9.2. CLINICS
9.2.1. Market size and forecast
9.3. HOSPITALS
9.3.1. Market size and forecast
9.4. AMBULATORY SURGERY CENTERS
9.4.1. Market size and forecast
9.5. HOME CARE SETTINGS
9.5.1. Market size and forecast
9.6. OTHERS
9.6.1. Market size and forecast
CHAPTER 10 WEARABLE INJECTORS MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA
10.2.1. Key market trends
10.2.2. Key growth factors and opportunities
10.2.3. Market size and forecast
10.2.3.1. U.S. market size and forecast
10.2.3.2. Canada market size and forecast
10.2.3.3. Mexico market size and forecast
10.2.4. North America Wearable Injectors Market by Type
10.2.5. North America Wearable Injectors Market by Usage
10.2.6. North America Wearable Injectors Market by Technology
10.2.7. North America Wearable Injectors Market by Mechanism of Injection
10.2.8. North America Wearable Injectors Market by Therapeutic Area
10.2.9. North America Wearable Injectors Market by End User
10.3. EUROPE
10.3.1. Key market trends
10.3.2. Key growth factors and opportunities
10.3.3. Market size and forecast
10.3.3.1. Germany market size and forecast
10.3.3.2. France market size and forecast
10.3.3.3. UK market size and forecast
10.3.3.4. Spain market size and forecast
10.3.3.5. Rest of Europe market size and forecast
10.3.4. Europe Wearable Injectors Market by Type
10.3.5. Europe Wearable Injectors Market by Usage
10.3.6. Europe Wearable Injectors Market by Technology
10.3.7. Europe Wearable Injectors Market by Mechanism of Injection
10.3.8. Europe Wearable Injectors Market by Therapeutic Area
10.3.9. Europe Wearable Injectors Market by End User
10.4. ASIA-PACIFIC
10.4.1. Key market trends
10.4.2. Key growth factors and opportunities
10.4.3. Market size and forecast
10.4.3.1. Japan market size and forecast
10.4.3.2. China market size and forecast
10.4.3.3. Australia market size and forecast
10.4.3.4. India market size and forecast
10.4.3.5. Rest of Asia-Pacific market size and forecast
10.4.4. Asia-Pacific Wearable Injectors Market by Type
10.4.5. Asia-Pacific Wearable Injectors Market by Usage
10.4.6. Asia-Pacific Wearable Injectors Market by Technology
10.4.7. Asia-Pacific Wearable Injectors Market by Mechanism of Injection
10.4.8. Asia-Pacific Wearable Injectors Market by Therapeutic Area
10.4.9. Asia-Pacific Wearable Injectors Market by End User
10.5. LAMEA
10.5.1. Key market trends
10.5.2. Key growth factors and opportunities
10.5.3. Market size and forecast
10.5.3.1. Brazil market size and forecast
10.5.3.2. Turkey market size and forecast
10.5.3.3. Saudi Arabia market size and forecast
10.5.3.4. South Africa market size and forecast
10.5.3.5. Rest of LAMEA market size and forecast
10.5.4. LAMEA Wearable Injectors Market by Type
10.5.5. LAMEA Wearable Injectors Market by Usage
10.5.6. LAMEA Wearable Injectors Market by Technology
10.5.7. LAMEA Wearable Injectors Market by Mechanism of Injection
10.5.8. LAMEA Wearable Injectors Market by Therapeutic Area
10.5.9. LAMEA Wearable Injectors Market by End User
CHAPTER 11 COMPANY PROFILES
11.1. ENABLE INJECTIONS
11.1.1. Operating business segments
11.1.2. Business performance
11.1.3. Key strategic moves and developments
11.2. STEADYMED THERAPEUTICS INC.
11.2.1. Operating business segments
11.2.2. Business performance
11.2.3. Key strategic moves and developments
11.3. INSULET CORPORATION
11.3.1. Operating business segments
11.3.2. Business performance
11.3.3. Key strategic moves and developments
11.4. UNILIFE CORPORATION
11.4.1. Operating business segments
11.4.2. Business performance
11.4.3. Key strategic moves and developments
11.5. SENSILE MEDICAL AG
11.5.1. Operating business segments
11.5.2. Business performance
11.5.3. Key strategic moves and developments
11.6. WEST PHARMACEUTICAL SERVICES, INC.
11.6.1. Operating business segments
11.6.2. Business performance
11.6.3. Key strategic moves and developments
11.7. BECTON, DICKINSON AND COMPANY
11.7.1. Operating business segments
11.7.2. Business performance
11.7.3. Key strategic moves and developments
11.8. BÜHLER MOTOR GMBH
11.8.1. Operating business segments
11.8.2. Business performance
11.8.3. Key strategic moves and developments
11.9. YPSOMED
11.9.1. Operating business segments
11.9.2. Business performance
11.9.3. Key strategic moves and developments
11.10. AMGEN INC.
11.10.1 Operating business segments
11.10.2 Business performance
11.10.3 Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Wearable Injectors Market- Global Opportunity Analysis and Industry Forecast, 2019-2026
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in Excel
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited within company/enterprise
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Buy Full Version
"Wearable Injectors Market"
Purchase Enquiry